This site is intended for health professionals only

Thursday 22 August 2019
Share |

Latest News

Dupilumab reaches primary and secondary endpoints in paediatric trial

Thursday 8th August 2019
A pivotal Phase III trial evaluating Dupixent® (dupilumab) in severe atopic dermatitis in children has met its primary and secondary endpoints. 
The topline data show that for children with severe atopic dermatitis (covering nearly 60% of their skin surface on average), adding Dupixent to standard-of-care topical corticosteroids (TCS) significantly improved measures of overall disease severity, skin clearing, itching and health-...
Thu, 1 Aug 2019
The brain activity of patients with depression, captured by MRI scans, may help doctors predict who will respond to cognitive behavioural therapy (CBT)
Thu, 1 Aug 2019
A scheme that pays hospitals to deliver high quality care has been shown to improve the outcomes for patients with broken hips in England
Wed, 31 Jul 2019
The World Health Organization estimates that 235 million people around the world suffer from asthma. But little is known about the impact of asthma on symptomatic people's ability to work.
Tue, 30 Jul 2019
The funds from the MS Society and Parkinson’s UK will enable an all-new digital brain bank, ambitious virtual reality initiative, and new research projects
Mon, 29 Jul 2019
The discovery adds further evidence to support the prenatal sex steroid theory of autism first proposed 20 years ago
Mon, 29 Jul 2019
The CHMP’s positive opinion is based on results from four randomised, controlled Phase III trials that incorporate data from more than 714 patients with either LGS or Dravet syndrome, two forms of epilepsy with high morbidity and mortality rates
Fri, 26 Jul 2019
Gastric cancer in Europe affects approximately 130,000 people a year, and it is estimated that 40% of those patients will have metastatic disease; for those with advanced or metastatic disease the treatment options are limited and are often palliative